In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
type: Dataset
description: International audience
issued: 2026-05-07T13:03:55.869928
language: en
modified: 2026-05-07T13:03:55.869935
contact point: Organization
  fn: CCSD
keyword: infoeu-reposemanticsarticle
keyword: journal-articles
keyword: mesh-adolescent
keyword: mesh-adult
keyword: mesh-aged
keyword: mesh-aged-80-and-over
keyword: mesh-biopsy
keyword: mesh-bone-marrow
keyword: mesh-female
keyword: mesh-fluorodeoxyglucose-f18
keyword: mesh-humans
keyword: mesh-lymphoma-large-b-cell-diffuse
keyword: mesh-male
keyword: mesh-middle-aged
keyword: mesh-multimodal-imaging
keyword: mesh-neoplasm-staging
keyword: mesh-positron-emission-tomography
keyword: mesh-prognosis
keyword: mesh-retrospective-studies
keyword: mesh-survival-analysis
keyword: mesh-tomography-x-ray-computed
keyword: mesh-young-adult
keyword: sdvibmnlife-sciences-q-biobioengineeringnuclear-medicine
landing page: 0161-5505

In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
type: Distribution
format: HTML
issued: 2026-05-07T13:03:55.872487
modified: 2026-05-07T13:03:55.834026
access URL: https://hal.science/hal-00927556

test_moissonnage_selune
type: Agent